NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
National Institutes of Health
…notice invites both early- and middle-phase exploratory clinical trials as well as later phas
Closes
Phase 3
2 funding calls
Upcoming first, then newest
Part the Cloud: Phase 1 and Phase 2 Clinical Studies — 2027 Funding
Alzheimer’s Association
…over two to three years; selected Phase 3 or biomarker-validation proposals can also qualify. Letters of intent are due 20 October 2026 at 17:00 Eastern time (22 October for ISTAART members); invited full applications follow on 15 December (17 December for members).
Closed